Corvus Pharmaceuticals CRVS Investment Purchases
Investment Purchases at other companies
Other financials
Where this comes from
Reported directly by Corvus Pharmaceuticals in its filing.
Tagged under the XBRL concept us-gaap:PaymentsToAcquireAvailableForSaleSecuritiesDebt.
The official record: Corvus Pharmaceuticals’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Corvus Pharmaceuticals's investment purchases.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Corvus Pharmaceuticals's investment purchases?
- Corvus Pharmaceuticals (CRVS) reported investment purchases of $161.74M in Q1 2026.
- How has Corvus Pharmaceuticals's investment purchases changed year-over-year?
- Corvus Pharmaceuticals's investment purchases increased by 1998.3% year-over-year, from $7.71M to $161.74M.
- What is the long-term trend for Corvus Pharmaceuticals's investment purchases?
- Over 4 years (2021 to 2025), Corvus Pharmaceuticals's investment purchases has grown at a 77.0% compound annual growth rate (CAGR), from $9.36M to $91.75M.
- What does investment purchases mean?
- Cash spent purchasing investment securities across all categories.